← Eichor
Study identifier: NCT07217899 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Condition: Blood Loss, Surgical · Blood Loss, Postoperative · Uterine Atony  ·  Sponsor: University of Michigan

PhasePhase 2
Planned participants140
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.

This description comes directly from the study's public registry record.

Talk to the study team

AnneMarie Opipari, MD  ·  734-763-8048  ·  opipari@med.umich.edu

Hero Eisley  ·  734-763-8048  ·  parkerdh@umich.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MichiganAnn Arbor, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07217899